| Role |
Name |
Disclosure |
Details |
| Author | Mark Rosenbloom, MD, MBA, FACEP, Adjunct Associate Professor of Medicine, Northwestern University Feinberg School of Medicine; Chief Executive Officer and Editorial Director, PEPID, LLC; Founder and Chairman, The Unicorn Children's Foundation | Nothing to disclose | Details | | Medical Editor | Richard Lavely, MD, JD, MS, MPH, Lecturer in Health Policy and Administration, Department of Public Health, Yale University School of Medicine | Nothing to disclose | Details | | Pharmacy Editor | John T VanDeVoort, PharmD, ABAT, Director of Pharmacy, Sacred Heart Hospital | Nothing to disclose | Details | | Managing Editor | Fred Harchelroad, MD, FACMT, Chair, Department of Emergency Medicine, Director of Medical Toxicology, Department of Emergency Medicine, Associate Professor, Allegheny General Hospital | Nothing to disclose | Details | | CME Editor | John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center | Nothing to disclose | Details | | Chief Editor | Asim Tarabar, MD, Assistant Professor, Department of Surgery, Section of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Fred Harchelroad, Managing Editor |
The contributor discloses no conflict of interest. |
|